Susceptibility-weighted imaging in malignant melanoma brain metastasis
Journal of Magnetic Resonance Imaging Sep 26, 2019
Schwarz D, Niederle T, Münch P, et al. - A total of 100 patients with melanoma brain metastases (BM) (69 having received radiotherapy [RT] and 31 RT-naïve) and a control group of 100 melanoma patients without BM were involved retrospectively to systematically investigate the spectrum of intracerebral findings in malignant melanoma (MM) BM on susceptibility-weighted imaging (SWI) and to discover the diagnostic value of SWI. SWI gave little additional diagnostic advantage over standard T1-weighted imaging, as melanin content alone does not lead to diagnostically appropriate SWI blooming. The signal transition of SWI may rather highlight secondary phenomena like microbleeding and/or metal scavenging. Isolated SWI artifacts do not compose vital tumor tissue however it represents unspecific microbleedings, RT-related parenchymal alterations or posttherapeutic remnants of prior metastatic lesions.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries